Syapse is the developer of a platform that works with leading health systems, life sciences companies, and regulators to accelerate real-world evidence to improve the outcomes of cancer patients.

Register for Details

For more details on financing and valuation for Syapse, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Syapse's ticker symbol?

Syapse does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Syapse's stock price?

The stock price for Syapse will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Syapse Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
2/2/2021 Series G-1 and G-2 $192.94MM $XXX.XX $XXX.XX
5/28/2020 Series F $112.62MM $XXX.XX $XXX.XX
4/23/2019 Series E $239.81MM $XXX.XX $XXX.XX
11/14/2017 Series D $130.43MM $XXX.XX $XXX.XX
1/12/2016 Series C $88.26MM $XXX.XX $XXX.XX
7/10/2014 Series B $30.83MM $XXX.XX $XXX.XX
1/1/2013 Series A $8.43MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Syapse

Forge green plus iconForge green minus icon

What is Syapse funding to date?

Syapse has raised $201.76MM with the following series:
$8.43MM for Series A, $30.83MM for Series B, $88.26MM for Series C, $130.43MM for Series D, $239.81MM for Series E, $112.62MM for Series F, $192.94MM for Series G-1 and G-2, $8.43MM for Series A, $30.83MM for Series B, $88.26MM for Series C, $130.43MM for Series D, $239.81MM for Series E, $112.62MM for Series F, $192.94MM for Series G-1 and G-2.
Forge green plus iconForge green minus icon

When was Syapse founded?

Syapse was founded in 2008.
Forge green plus iconForge green minus icon

Can you invest in Syapse?

Syapse is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Syapse share pre-IPO?

If you own Syapse pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Syapse a publicly traded company?

Syapse is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Syapse in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
 
 
Sector
Last Round Est. Valuation
$1.08B